Congenital heart disease: six decades of progress

P M Olley1

  • 1Department of Pediatrics, University of Alberta, Edmonton, Canada.

Insights

Congenital heart malformations affect 1% of newborns. Advances in surgical and interventional cardiology, alongside improved diagnostics like echocardiography, offer better management for complex heart defects.

Area of Science:

  • Cardiology
  • Pediatric Cardiology
  • Congenital Heart Disease

Background:

  • Congenital heart malformations (CHMs) are prevalent, affecting approximately 1 in 100 live births.
  • Significant advancements have been made in surgical and interventional cardiology for CHMs since the first successful persistent ductus arteriosus ligation.
  • Neurological complications are a common concern in patients with congenital heart disease.

Purpose of the Study:

  • To review the progress in surgical and interventional management of congenital heart lesions.
  • To highlight current diagnostic modalities and their expanding applications.
  • To discuss challenging CHMs and the prevalence of neurological complications.

Main Methods:

  • Review of historical and recent advancements in surgical and interventional cardiology.
  • Discussion of diagnostic imaging techniques including echocardiography, Doppler studies, transesophageal studies, and magnetic resonance imaging.
  • Focus on complex congenital heart lesions and associated neurological complications.

Main Results:

  • Interventional cardiology offers alternatives to surgery for numerous congenital heart lesions.
  • Echocardiography with Doppler is the primary diagnostic tool, enhanced by transesophageal studies.
  • Magnetic resonance imaging aids in visualizing lesions not clearly seen on echocardiography.
  • Hypoplastic left heart syndrome and pulmonary atresia variants remain challenging.

Conclusions:

  • Modern cardiology provides diverse and effective treatment options for congenital heart disease.
  • Advanced imaging techniques improve diagnostic accuracy for complex CHMs.
  • Neurological complications represent a significant area requiring continued attention in CHDs.

Related Concept Videos

Development of the Heart01:27

Development of the Heart

The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart tube by...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...